BiomX Statistics
Total Valuation
BiomX has a market cap or net worth of $8.88 million. The enterprise value is $7.71 million.
Important Dates
The last earnings date was Wednesday, May 20, 2026, after market close.
| Earnings Date | May 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BiomX has 10.15 million shares outstanding. The number of shares has increased by 114.80% in one year.
| Current Share Class | 10.15M |
| Shares Outstanding | 10.15M |
| Shares Change (YoY) | +114.80% |
| Shares Change (QoQ) | +30.19% |
| Owned by Insiders (%) | 3.45% |
| Owned by Institutions (%) | 5.15% |
| Float | 7.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.24
| Current Ratio | 1.24 |
| Quick Ratio | 0.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -403.76% and return on invested capital (ROIC) is -92.90%.
| Return on Equity (ROE) | -403.76% |
| Return on Assets (ROA) | -62.52% |
| Return on Invested Capital (ROIC) | -92.90% |
| Return on Capital Employed (ROCE) | -3,042.29% |
| Weighted Average Cost of Capital (WACC) | 10.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.39M |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BiomX has paid $6,000 in taxes.
| Income Tax | 6,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.60% in the last 52 weeks. The beta is 1.19, so BiomX's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -90.60% |
| 50-Day Moving Average | 1.85 |
| 200-Day Moving Average | 5.48 |
| Relative Strength Index (RSI) | 42.40 |
| Average Volume (20 Days) | 16,010,118 |
Short Selling Information
The latest short interest is 197,532, so 1.95% of the outstanding shares have been sold short.
| Short Interest | 197,532 |
| Short Previous Month | 78,198 |
| Short % of Shares Out | 1.95% |
| Short % of Float | 2.53% |
| Short Ratio (days to cover) | 0.43 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -24.46M |
| Pretax Income | -47.67M |
| Net Income | -47.77M |
| EBITDA | -21.04M |
| EBIT | -24.46M |
| Earnings Per Share (EPS) | -$24.15 |
Full Income StatementBalance Sheet
The company has $1.17 million in cash and n/a in debt, with a net cash position of $1.17 million or $0.12 per share.
| Cash & Cash Equivalents | 1.17M |
| Total Debt | n/a |
| Net Cash | 1.17M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | -881,000 |
| Book Value Per Share | -2.98 |
| Working Capital | 596,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$23.09 million and capital expenditures -$2,000, giving a free cash flow of -$23.09 million.
| Operating Cash Flow | -23.09M |
| Capital Expenditures | -2,000 |
| Depreciation & Amortization | 3.42M |
| Net Borrowing | n/a |
| Free Cash Flow | -23.09M |
| FCF Per Share | -$2.28 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
